# Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)

> **NCT00075816** · PHASE3 · COMPLETED · sponsor: **Medical College of Wisconsin** · enrollment: 551 (actual)

## Conditions studied

- Leukemia
- Myeloproliferative Disorders
- Myelodysplastic-Myeloproliferative Diseases

## Interventions

- **BIOLOGICAL:** Allogeneic bone marrow transplantation
- **BIOLOGICAL:** Peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00075816
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2013-04
- **Final completion:** 2014-04
- **Target enrollment:** 551 (ACTUAL)
- **Last updated:** 2023-01-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075816, "Peripheral Blood Stem Cell Transplant vs Bone Marrow Transplant in Individuals With Hematologic Cancers (BMT CTN 0201)". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00075816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*